Search the GenomeWeb Intelligence Network




Biotech Transfer Week
GenomeWeb News Premium Content
Existing subscribers login here.
Biotech Transfer Week is Now FREE - Everyone Can Subscribe!

Volume 2 - Number 26 | July 2, 2008

Subscriber Login
Subscribe to Biotech Transfer Week
Site Licenses
RSS Feed
Archives


In This Week's Issue

Calif. Stem-Cell Leaders Begin Planning For ‘Sustainability’ After Proposition 71

Report: Top Biotech States to Reap Biggest Gains from Proposed NIH Funding Increase

Consultant in TGen Development Helps Bring Luxembourg, Three US Institutions Together

Research Triangle Park, Syngenta, Cheminova, East Palo Alto Planning Commission, Bay Business Park, P/S/L Group America, BioBusiness Park at Elk Run, Merck, Treyburn Corporate Park, State of North Carolina

California Net Operating Loss Carry Forwards, Clinical Research Consortium of Massachusetts, North Shore Life Sciences Accelerator, Michigan Strategic Fund Board, MichBio, Industrial Development Agency Ireland, New York Power Authority

Stephen Hurly, Mark Schoenebaum, Robyn Karnauskas, Greg Tronto, David Girling, Lorraine Keller, Maureen O’Leary

Features
Ohio’s Third Frontier Awards $23M to Public-Private Biomed Research Projects
Six public-private research groups will share the cash, which will come from the Third Frontier’s Ohio Biomedical Research Commercialization Program. According to an OBRCP official, the program is increasingly funding projects that are more applied in nature and have a more defined commercialization goal.

Ariz. Institute’s ‘Virtual Incubator’ Aims To Nurture Biotech Alliances, Start-Ups
ThirdBiotech Research Group, which was incorporated last year, will bring together Arizona-based research institutes, universities, and companies to provide wet lab space, business services and mentoring, and technology-commercialization assistance to life-sciences entrepreneurs and fledgling companies in an attempt to benefit the greater biosciences economy in Arizona.

BTW Q&A
UNC-Greensboro Economists Uncover Factors That Help Bring NIH SBIR Projects to Market
The researchers examined the long-term commercialization prospects of 405 SBIR Phase II grants awarded by the NIH between 1992 and 2001, and identified external factors that contributed to successful technology commercialization. Co-author Christopher Ruhm discussed some of the results in an interview with BTW.

News Briefs
USPTO, Wisconsin Alumni Research Foundation, GWC Technologies, Boston University, Elixir Pharmaceuticals, ConocoPhillips, Colorado Center for Biorefining and Biofuels, RegeneRx Biopharmaceuticals, Maryland Industrial Partnerships, World Intellectual Property Organization, Global Technology Transfer Group, Lixte Biotechnology Holdings, National Institute of Neurological Disorders and Stroke, NIH, Modern Biosciences, University of Bradford


People in the News
Gillian Small, Greg Tronto, Lorraine Keller, Maureen O’Leary



Copyright © 2008 GenomeWeb LLC. All rights reserved.

Publishing Systems Powered by iProduction [martha]